In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS

 

ESC Webinar Series - Diabetes. Focus on the evidence for SGLT2i in the prevention and treatment of heart failure. SGLT2i – A new class of drugs for the treatment of heart failure.

Session HFA Webinars 2020

Speaker Giuseppe M C Rosano, Marco Metra, Mark Petrie

Event : Webinar 2020

  • Topic : preventive cardiology
  • Sub-topic : Diabetes and the Heart
  • Date : 03 December 2020
  • Session type : Webinar
  • Supported by AstraZeneca as well as Boehringer Ingelheim and Lilly Alliance as an educational grant.

This content is currently on FREE ACCESS

 

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are